A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis

Clinical trial NCT05486208 · TERMINATED

Trial details

NCT number: NCT05486208
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Dermatitis, Atopic

Start date: 2022-08-11
Primary completion: 2024-01-20
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.